Want to join the conversation?
Global biotechnology company $VRTX said the European Commission has approved the expanded use of the KALYDECO (ivacaftor) drug for the treatment of cystic fibrosis, a genetic disorder that affects the lungs and other organs in children aged 2 to 5 having one of nine gating mutations and in adults aged 18 and older having R117H mutation.
$BA won a $22 billion deal from SpiceJet, their largest order from an Indian airline.
$FB stock remained in the green territory after Raymond James upgraded shares to strong buy from outperform, on expectations that overall 4Q16 ad spending was strong.
$ARRY Good day for the stock, jumped 7%. Great gains !
2017 was supposed to be another record year for automotive industry. Still, $F Ford thinks its profit will dip in 2017..!!
$KKR to buy Hitachi’s power tool unit Hitachi Koki for $1.3 billion. Looks like KKR & Co is going strong in Japan! Remember when it bought Calsonic Kansei a while back?